ArticleCardiovascular drugs and therapy2024

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.

Wei-Chieh Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.